• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶在体内是表皮增殖的正向调节因子。

Urokinase is a positive regulator of epidermal proliferation in vivo.

作者信息

Jensen P J, Lavker R M

机构信息

Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia 19104-6142, USA.

出版信息

J Invest Dermatol. 1999 Feb;112(2):240-4. doi: 10.1046/j.1523-1747.1999.00494.x.

DOI:10.1046/j.1523-1747.1999.00494.x
PMID:9989802
Abstract

The epidermis is a self-renewing tissue that must maintain a basal proliferative rate as well as respond to various perturbing stimuli. Regulation of keratinocyte proliferation involves diverse molecules, including growth factors, ions, and hormones. We recently proposed that a proteinase, urokinase-type plasminogen activator (uPA) may be added to this list, based on correlative evidence linking expression of uPA and murine epidermal hyperproliferation. Here we report that, during the first 3 d of life, the epidermis from mice that bear a targeted deletion of the uPA gene has a significantly lower proliferative rate than the epidermis from wild-type mice. In contrast, proliferation in the matrix keratinocytes of the hair follicles is not decreased in neonatal uPA-/- mice. Vertical migration of keratinocytes during terminal differentiation was not affected. We therefore conclude that lack of uPA is associated with a decrease in epidermal proliferation.

摘要

表皮是一种自我更新的组织,必须维持基础增殖速率并对各种干扰刺激作出反应。角质形成细胞增殖的调节涉及多种分子,包括生长因子、离子和激素。基于将尿激酶型纤溶酶原激活剂(uPA)的表达与小鼠表皮过度增殖联系起来的相关证据,我们最近提出蛋白酶uPA也可能属于这一类别。在此我们报告,在出生后的头3天,uPA基因靶向缺失的小鼠的表皮增殖速率明显低于野生型小鼠的表皮。相比之下,新生uPA - / -小鼠毛囊基质角质形成细胞的增殖并未降低。终末分化期间角质形成细胞的垂直迁移不受影响。因此我们得出结论,uPA的缺乏与表皮增殖的降低有关。

相似文献

1
Urokinase is a positive regulator of epidermal proliferation in vivo.尿激酶在体内是表皮增殖的正向调节因子。
J Invest Dermatol. 1999 Feb;112(2):240-4. doi: 10.1046/j.1523-1747.1999.00494.x.
2
Modulation of the plasminogen activator cascade during enhanced epidermal proliferation in vivo.体内表皮增殖增强过程中纤溶酶原激活物级联反应的调节
Cell Growth Differ. 1996 Dec;7(12):1793-804.
3
Urokinase plasminogen activator (uPA) is a positive regulator of outer root sheath keratinocyte proliferation.尿激酶型纤溶酶原激活剂(uPA)是外根鞘角质形成细胞增殖的正向调节因子。
Cell Biol Int. 2004;28(8-9):571-5. doi: 10.1016/j.cellbi.2004.04.012.
4
Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes.鞘氨醇磷酸胆碱刺激培养的人角质形成细胞增殖并上调细胞表面相关纤溶酶原激活物活性。
J Invest Dermatol. 1998 Mar;110(3):253-8. doi: 10.1046/j.1523-1747.1998.00120.x.
5
Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.在器官型共培养系统中角质形成细胞分化过程中尿激酶型纤溶酶原激活剂(uPA)、其受体(uPA-R)和2型抑制剂(PAI-2)的差异表达。
Exp Cell Res. 1995 Oct;220(2):415-23. doi: 10.1006/excr.1995.1333.
6
Dispase-mediated basal detachment of cultured keratinocytes induces urokinase-type plasminogen activator (uPA) and its receptor (uPA-R, CD87).Dispase介导的培养角质形成细胞基底脱离可诱导尿激酶型纤溶酶原激活剂(uPA)及其受体(uPA-R,CD87)。
Exp Cell Res. 1996 Nov 1;228(2):246-53. doi: 10.1006/excr.1996.0323.
7
Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.尿激酶诱导的平滑肌细胞反应需要不同的信号通路:表皮生长因子受体的作用。
J Vasc Surg. 2005 Apr;41(4):672-81. doi: 10.1016/j.jvs.2005.01.007.
8
Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.基底角质形成细胞中纤溶酶原激活物抑制剂2的过表达增强转基因小鼠乳头瘤的形成。
Cancer Res. 2001 Feb 1;61(3):970-6.
9
Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF-alpha/EGF receptor.通过转化生长因子-α/表皮生长因子受体对角质形成细胞尿激酶型纤溶酶原激活剂的自分泌/旁分泌调节
J Cell Physiol. 1993 May;155(2):333-9. doi: 10.1002/jcp.1041550214.
10
Relationship between urokinase plasminogen activator receptor (uPAR) and the invasion of human prenatal hair follicle.尿激酶型纤溶酶原激活物受体(uPAR)与人类胚胎毛囊侵袭的关系。
Arch Dermatol Res. 2010 Aug;302(6):409-18. doi: 10.1007/s00403-009-1010-2. Epub 2009 Dec 13.

引用本文的文献

1
Autophagy plays a positive role in induction of epidermal proliferation.自噬在诱导表皮增殖中发挥积极作用。
FASEB J. 2020 Aug;34(8):10657-10667. doi: 10.1096/fj.202000770RR. Epub 2020 Jun 29.
2
Plau and Tgfbr3 are YAP-regulated genes that promote keratinocyte proliferation.Plau 和 Tgfbr3 是 YAP 调节的基因,可促进角质形成细胞增殖。
Cell Death Dis. 2018 Oct 31;9(11):1106. doi: 10.1038/s41419-018-1141-5.
3
Changes in tension regulates proliferation and migration of fibroblasts by remodeling expression of ECM proteins.
张力的变化通过重塑细胞外基质蛋白的表达来调节成纤维细胞的增殖和迁移。
Exp Ther Med. 2016 Sep;12(3):1542-1550. doi: 10.3892/etm.2016.3497. Epub 2016 Jul 1.
4
Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.转化生长因子-β与尿激酶型纤溶酶原激活剂:肿瘤发生中的危险组合——对皮肤癌的影响
ISRN Dermatol. 2013 Jul 18;2013:597927. doi: 10.1155/2013/597927. eCollection 2013.
5
EEDA: a protein associated with an early stage of stratified epithelial differentiation.EEDA:一种与复层上皮分化早期相关的蛋白质。
J Cell Physiol. 2006 Jan;206(1):103-11. doi: 10.1002/jcp.20433.
6
Epidermal expression of serine protease, neuropsin (KLK8) in normal and pathological skin samples.丝氨酸蛋白酶神经蛋白酶(KLK8)在正常和病理皮肤样本中的表皮表达。
Mol Pathol. 2002 Aug;55(4):235-41. doi: 10.1136/mp.55.4.235.
7
Overexpression of urokinase-type plasminogen activator in human gastric cancer cell line (AGS) induces tumorigenicity in severe combined immunodeficient mice.尿激酶型纤溶酶原激活剂在人胃癌细胞系(AGS)中的过表达可诱导严重联合免疫缺陷小鼠产生致瘤性。
Jpn J Cancer Res. 2002 Feb;93(2):151-6. doi: 10.1111/j.1349-7006.2002.tb01253.x.
8
Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.尿激酶型纤溶酶原激活剂及其受体协同促进致病性蛋白水解。
EMBO J. 2000 Sep 1;19(17):4817-26. doi: 10.1093/emboj/19.17.4817.